Search results

Yeah we can go down with that theoretical rabbit hole as to what is happening with this virus, and other viruses in general. What are you saying may be true, at least with some viruses. I just don’t know with any certainty what’s happening.

Yeah, I saw it this morning. Two things. The study is not peer reviewed yet. So we have to wait for that. Also, I haven’t seen the study design. Secondly, and just as importantly, there is no dexamthasone in any of the treatment arms, apparently. Remdesivir, at least in the US, is most...

What you posted gives zero proof that Saban ‘will live”. Based on what we know about the virus and Saban, he will live not because of any drugs, but because as far as we know he is a healthy man, and even if you are over 60, if you are overall healthy and have no severe comorbidities, you still...

Because the preliminary data looks solid, but it’s still a risk. It’s an educated guess that they think it is safe and effective based solely on preliminary data, which is not good enough to get it FDA approval for the general public. It’s almost a calculated crapshoot using these agents...

What do these examples prove? You’re big on generalities, and extremely light or nonexistent on specifics

“The best” that money can buy is irrelevant in this case. The actual situation is as I explained above. You have one unapproved monoclonal antibody treatment that is in extremely limited supply, is in early trails, is unproven for widespread use, and which carries a risk/benefit profile which...

If you’re talking about Regeneron, nobody knows if it actually works or not, it’s super early in clinical trials and is not approved for patient use unless administered through the “compassionate use”exception. It has yet to be proven safe or effective, no matter how positive it looks in the...